TNF and breast carcinoma: The staining of the inhibitory immune-receptor ligand programmed death-ligand 2 (PD-L2) and tumor necrosis factor-alpha (TNF-α) ligand OX40L in human breast cancer sections revealed T lymphocytes at the surface of CAF.